Oscar Health, Inc. (NYSE:OSCR) Receives $21.56 Average Price Target from Analysts

Oscar Health, Inc. (NYSE:OSCR) has been given an average rating of “Hold” by the nine analysts that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $21.56.

A number of equities research analysts recently commented on the company. Jefferies Financial Group started coverage on Oscar Health in a research report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price on the stock. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. UBS Group began coverage on Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price for the company. Finally, Piper Sandler restated an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th.

Insider Buying and Selling

In other news, COO Steven Wolin sold 19,580 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $354,006.40. Following the completion of the sale, the chief operating officer now directly owns 102,598 shares of the company’s stock, valued at approximately $1,854,971.84. The trade was a 16.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm’s stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $17.05, for a total transaction of $426,250.00. Following the completion of the transaction, the director now directly owns 89,512 shares in the company, valued at $1,526,179.60. This represents a 21.83 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Oscar Health

Institutional investors and hedge funds have recently bought and sold shares of the company. Neo Ivy Capital Management purchased a new stake in shares of Oscar Health in the 3rd quarter worth approximately $600,000. Geode Capital Management LLC raised its stake in Oscar Health by 11.7% in the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock worth $92,062,000 after buying an additional 455,205 shares in the last quarter. Barclays PLC lifted its holdings in Oscar Health by 217.5% during the third quarter. Barclays PLC now owns 325,818 shares of the company’s stock worth $6,911,000 after buying an additional 223,189 shares during the period. Y Intercept Hong Kong Ltd purchased a new stake in Oscar Health during the third quarter worth $2,764,000. Finally, Soros Fund Management LLC bought a new stake in Oscar Health during the 3rd quarter valued at $12,726,000. 75.70% of the stock is owned by institutional investors.

Oscar Health Trading Up 4.4 %

Oscar Health stock opened at $14.09 on Wednesday. Oscar Health has a 1 year low of $8.14 and a 1 year high of $23.79. The firm’s 50 day moving average price is $15.89 and its 200-day moving average price is $17.42. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market cap of $3.48 billion, a P/E ratio of -234.79 and a beta of 1.63.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion for the quarter, compared to analysts’ expectations of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business’s revenue was up 68.3% on a year-over-year basis. During the same period in the previous year, the business posted ($0.29) earnings per share. On average, equities analysts predict that Oscar Health will post -0.01 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.